尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Wilson Marc, 首席财务官. Insider active across 1 company, notably Crinetics Pharmaceuticals, Inc.. In total, 12 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €200k. History available since 28 February 2022. The latest transaction was disclosed on 26 September 2024 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Wilson Marc is Directeur Financier at Crinetics Pharmaceuticals, Inc. (XNAS). He has 12 filings in total, and in the recent sample of 12 filings covered here, the recorded activity runs from 2022-03-02 to 2024-09-30, with 0 EUR of buys and 199630 EUR of sells, and the most common transaction nature is Levée d'options.